The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Two Cases of Lactobacillus Bacteremia During Probiotic Treatment of Short Gut Syndrome
Abstract
Lactobacillus, a gram-positive bacillus, is a constituent of the indigenous flora of the colon. Often used as a probiotic agent, it appears to help prevent both intestinal colonization by pathogenic organisms and bacterial overgrowth syndrome. Lactobacillus organisms in the intestine are thought to produce acetic acid, lactic acid, and hydrogen peroxide and to promote the secretion of antimicrobial substances. The production of short chain fatty acids and the resultant low luminal pH of the colon also appear to inhibit growth of bacterial pathogens (1). Lactobacillus may also compete with pathogenic organisms for mucosal surface receptors and may decrease the incidence of antibiotic-associated diarrhea and Clostridium difficile colitis (2). Although Lactobacillus generally is not considered a pathogen, it can cause disease in compromised hosts, including bacterial endocarditis, pleuropulmonary infections, gastrointestinal abscesses, urinary tract infection, conjunctivitis, dental caries, and endometritis (3). Lactobacillus bacteremia, presumably secondary to bacterial translocation from the gastrointestinal tract, has been reported in a patient with severe intestinal inflammation caused by ulcerative colitis (4). There are no published reports of bacteremia or sepsis secondary to Lactobacillus given as a probiotic agent. We report two cases of Lactobacillus GG sepsis occurring during the therapeutic use of this organism. CASE REPORTS Case 1 Patient 1 was a 36-week-gestation male infant with short gut syndrome secondary to congenital intestinal atresia and volvulus. The patient was dependent on total parenteral nutrition (TPN) because of his very short residual intestine. He had experienced cholestasis. A regimen of Lactobacillus GG (Culturelle, ConAgra, Omaha, Nebraska) supplementation was started on the 95th day of life, with the patient receiving the contents of 1 capsule daily via gastrostomy tube without apparent complication. On the 23rd day of supplementation, the patient experienced fever and diarrhea, with signs and symptoms consistent with sepsis or infection. Blood cultures were obtained, and antibiotic therapy with ceftriaxone and ampicillin was initiated. Within 48 hours, blood cultures grew a Lactobacillus species sensitive to ampicillin. Blood cultures taken after 10 days of treatment with ampicillin were negative. Although fingerprinting of the isolate was not performed, we suspected that the source of the lactobacillus sepsis might have been the exogenous probiotic. Lactobacillus GG supplementation was discontinued, and the patient had no additional Lactobacillus bacteremia. On endoscopy, the patient’s intestine was inflamed and friable. We suspect that the fragility of the intestine may have promoted transmigration of the supplemental Lactobacillus GG. Case 2 Patient 2 was a 34-week-gestation male infant with gastroschisis. At delivery, most of the intestine was infarcted, leaving the infant with approximately 16 cm of bowel distal to the ligament of Treitz. He underwent a gastrostomy and jejunostomy shortly after birth, was dependent on TPN, and rapidly developed cholestatic liver disease. He began a regimen of Lactobacillus GG, 1 capsule by mouth daily, on day of life 17. It was hoped the regimen would prevent bacterial overgrowth of the small intestine. He tolerated the preparation well. On day of life 186, he experienced an elevated temperature, tachycardia, and increased apneic events. Cultures were obtained, and ceftriaxone and ampicillin were administered. Within 48 hours, the blood cultures grew Lactobacillus sensitive to both antibiotics. The Lactobacillus GG supplement was discontinued, and the patient completed a 10-day course of ceftriaxone and ampicillin without complications. His repeat blood cultures while receiving antibiotics were negative, and he had no additional episodes of Lactobacillus bacteremia. Upper endoscopy after the sepsis episode revealed mild inflammation of the intestine. As in case 1, we suspected that the patient’s intestinal inflammation led to translocation of Lactobacillus GG from the intestinal lumen. In this case, we confirmed through DNA fingerprinting that the strain of Lactobacillus in the probiotic supplement was identical to the strain causing sepsis. DNA fingerprinting was performed at the University of Washington Department of Clinical Microbiology using pulsed field gel electrophoresis of chromosomal DNA with SMA1, SFi1, and Not1 digests according to standard protocol. The supplemental strain was indistinguishable from the blood culture isolate (Fig. 1).FIG. 1.: Pulsed-gel electrophoresis of Lactobacillus GG sample and Case 2 bloodsample using SFi1, Not1, and SMA1 digests. Lane #1 is the control for the gel. Lanes #2 and 4 for each digest are Case 2 blood sample. Lanes #3 and 5 for each digest are Lactobacillus GG sample.DISCUSSION Sepsis related to Lactobacillus GG supplementation in short bowel syndrome has not previously been reported. Both
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Case reports of LB have hypothesized that, in some cases, the source of the lactobacilli was the oral probiotic the patient was taking. However, this correlation was based on medical history alone or microbiologic cultures or assays that were unable to distinguish different Lactobacillus strains, or the strains themselves were not reported; thus, the hypothesis could not be supported [41,42,43].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [42]
In the citing paper
“Our review of the literature (from 1980 to 2023) found 23 cases where the blood isolate from a bacteremic patient was identical to the probiotic strain the patient had been taking.”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [42]
In the citing paper
“Similarly, Kunz et al. described two cases of children with SBS who developed Lactobacillus bacteremia during treatment with probiotics containing LGG. Both patients had severe impairment of intestinal integrity and were dependent on parenteral nutrition. Blood cultures were positive for Lactobacillus species, and molecular analyses of the blood isolates and the administered probiotics”
From Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence (2026) · cites this paper as [29]
In the citing paper
“AEs include life-threatening pneumonia,106 endocarditis,107–111 and sepsis.112–115”
From Emerging issues in probiotic safety: 2023 perspectives (2023) · cites this paper as [112]
Citations
Cites
Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children
Vanderhoof, J. A., Whitney, D. B., Antonson, D. L., Hanner, T. L., Lupo, J. V., & Young, R. J. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70053-3 · Cited by 536 · cited 1×
“Lactobacillus may also compete with pathogenic organisms for mucosal surface receptors and may decrease the incidence of antibiotic-associated diarrhea and Clostridium difficile colitis (2).”
BackgroundTreatment Strategies for Small Bowel Bacterial Overgrowth in Short Bowel Syndrome
Vanderhoof, J. A., Young, R. J., Murray, N., & Kaufman, S. S. (1998) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1998.tb01126.x · Cited by 168 · cited 2×
“The production of short chain fatty acids and the resultant low luminal pH of the colon also appear to inhibit growth of bacterial pathogens (1).”
BackgroundLactobacillus casei subsp. rhamnosus Sepsis in a Patient With Ulcerative Colitis
Farina, C., Arosio, M. E. G., Mangia, M., & Moioli, F. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200109000-00019 · Cited by 67 · cited 1×
“Lactobacillus bacteremia, presumably secondary to bacterial translocation from the gastrointestinal tract, has been reported in a patient with severe intestinal inflammation caused by ulcerative colitis (4).”
Background
Research works printed but not linked: 1
- Vanderhoof, 1998, J Pediatr Gastroenterol Nutr, 27, 155, 10.1097/00005176-199808000-00005 · doi:10.1097/00005176-199808000-00005 · Paper page
Cited by
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Doron, S., & Snydman, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ085 · Cited by 942
Safety assessment of probiotics for human use
Sanders, M. E., Akkermans, L. M. A., Haller, D., Hammerman, C., Heimbach, J. T., Hörmannsperger, G., & Huys, G. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12127 · Cited by 816
“rhamnosus GG sepsis in a complicated post-operative period following repair of a double-outlet right ventricle and pulmonary stenosis and a report of two infants with short gut syndrome.(3,12) For these cases the clinical blood isolate and supplemental probiotic underwent DNA fingerprinting by repetitive element seque…”
BackgroundProbiotic use in clinical practice: what are the risks?
Boyle, R. J., Robins-Browne, R. M., & Tang, M. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1256 · Cited by 776
“Kunz et al (26) described the cases of 2 premature infants with short gut syndrome who were fed via gastrostomy or jejunostomy and developed Lactobacillus bacteremia while taking LGG supplements In 1 of the 2 cases, pulsed-field gel electrophoresis of chromosomal DNA restriction fragments found the bacteremic strain a…”
BackgroundESPEN guidelines on chronic intestinal failure in adults
Pironi, L., Arends, J., Bozzetti, F., Cuerda, C., Gillanders, L., Jeppesen, P. B., Joly, F., Kelly, D., Lal, S., Staun, M., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.01.020 · Cited by 722
“However, in children, cases of bacteremia with the ingested probiotic bacteria have been described in SBS patients depending on PN [240,241].”
Background
Metadata
- Authors
- Kunz, A. N., Noel, J. M., & Fairchok, M. P.
- Affiliations
- Madigan Army Medical Center (US)
- Corresponding author
- Kunz, Anjali N.
- ORCID
- Fairchok, Mary P.
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 38
- Issue
- 4
- Pages
- 457-458
- ISSN
- 0277-2116 (ISSN-L)
- OpenAlex
- W1994103968
- Cited by
- 319
- References
- 3
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 18 · 2022: 16 · 2021: 17 · 2020: 8 · 2019: 15 · 2018: 16 · 2017: 13 · 2016: 14 · 2015: 21 · 2014: 24 · 2013: 13 · 2012: 25
- FWCI
- 19.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- Lactobacillus rhamnosus GG, short bowel syndrome, congenital intestinal atresia, total parenteral nutrition, sepsis, bacterial translocation, probiotic safety, neonatal infection, Lactobacillus acidophilus, Lactobacillus reuteri
- MeSH terms
- Humans, Infant, Newborn, Lactobacillus, Male, Short Bowel Syndrome, Bacteremia, Gram-Positive Bacterial Infections, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Two Cases of Lactobacillus Bacteremia During Probiotic Treatment of Short Gut Syndrome. https://app.cochat.ai/papers/10.1097/00005176-200404000-00017
- The paper
- Kunz, A. N., Noel, J. M., & Fairchok, M. P. (2004). Two Cases of Lactobacillus Bacteremia During Probiotic Treatment of Short Gut Syndrome. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/00005176-200404000-00017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.